Page 18 - OR-1-2

4. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB. 2015;22:237-270.
Midbrain dopaminergic cell loss in Parkinson’s disease: doi: 10.1007/7854-2014-356
Computer visualization. Ann Neurol. 1989;26(4):507-514.
16. Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells
doi: 10.1002/ana.410260403
build crypt-villus structures in vitro without a mesenchymal
5. Cookson MR. Alpha-synuclein and neuronal cell death. Mol niche. Nature. 2009;459(7244):262-265.
Neurodegener. 2009;4:9.
doi: 10.1038/nature07935
doi: 10.1186/1750-1326-4-9
17. Smits LM, Reinhardt L, Reinhardt P, et al. Modeling
6. Pickrell AM, Youle RJ. The roles of PINK1, parkin, and Parkinson’s disease in midbrain-like organoids. NPJ
mitochondrial fidelity in Parkinson’s disease. Neuron. Parkinsons Dis. 2019;5:5.
2015;85(2):257-273.
doi: 10.1038/s41531-019-0078-4
doi: 10.1016/j.neuron.2014.12.007
18. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation
7. Hirsch EC, Hunot S. Neuroinflammation in Parkinson’s in the alpha-synuclein gene identified in families with
disease: A target for neuroprotection? Lancet Neurol. Parkinson’s disease. Science. 1997;276(5321):2045-2047.
2009;8(4):382-397.
doi: 10.1126/science.276.5321.2045
doi: 10.1016/S1474-4422(09)70062-6
19. Oliveira LM, Falomir-Lockhart LJ, Botelho MG, et al.
8. Pang SY, Lo RC, Ho PW, et al. LRRK2, GBA and their Elevated α-synuclein caused by SNCA gene triplication
interaction in the regulation of autophagy: Implications on impairs neuronal differentiation and maturation in
therapeutics in Parkinson’s disease. Transl Neurodegener. Parkinson’s patient-derived induced pluripotent stem cells.
2022;11(1):5. Cell Death Dis. 2015;6(11):e1994.
doi: 10.1186/s40035-022-00281-6 doi: 10.1038/cddis.2015.318
9. Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in 20. Mohamed NV, Sirois J, Ramamurthy J, et al. Midbrain
Parkinson disease - from basic research to the clinic. Nat Rev organoids with an SNCA gene triplication model key features
Neurol. 2022;18(8):476-495. of synucleinopathy. Brain Commun. 2021;3(4):fcab223.
doi: 10.1038/s41582-022-00681-2 doi: 10.1093/braincomms/fcab223
10. Schober A. Classic toxin-induced animal models of 21. Becerra-Calixto A, Mukherjee A, Ramirez S, et al. Lewy
Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res. body-like pathology and loss of dopaminergic neurons
2004;318(1):215-224. in midbrain organoids derived from familial Parkinson’s
disease patient. Cells. 2023;12(4):625.
doi: 10.1007/s00441-004-0938-y
doi: 10.3390/cells12040625
11. Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii MR,
Levesque M. Animal models of Parkinson’s disease: Bridging 22. Muwanigwa MN, Modamio-Chamarro J, Antony PM,
the gap between disease hallmarks and research questions. et al. Alpha-synuclein pathology is associated with astrocyte
Transl Neurodegener. 2023;12(1):36. senescence in a midbrain organoid model of familial
Parkinson’s disease. Mol Cell Neurosci. 2024;128:103919.
doi: 10.1186/s40035-023-00368-8
doi: 10.1016/j.mcn.2024.103919
12. De Haas R, Heltzel LC, Tax D, et al. To be or not to be pink(1):
Contradictory findings in an animal model for Parkinson’s 23. Patikas N, Ansari R, Metzakopian E. Single-cell
disease. Brain Commun. 2019;1(1):fcz016. transcriptomics identifies perturbed molecular pathways
in midbrain organoids using α-synuclein triplication
doi: 10.1093/braincomms/fcz016
Parkinson’s disease patient-derived iPSCs. Neurosci Res.
13. Giraldez-Perez R, Antolin-Vallespin M, Munoz M, Sanchez- 2023;195:13-28.
Capelo A. Models of α-synuclein aggregation in Parkinson’s
disease. Acta Neuropathol Commun. 2014;2:176. doi: 10.1016/j.neures.2023.06.001
24. Chandra R, Sokratian A, Chavez KR, et al. Gut mucosal
doi: 10.1186/s40478-014-0176-9
cells transfer α-synuclein to the vagus nerve. JCI Insight.
14. Li X, Patel JC, Wang J, et al. Enhanced striatal dopamine 2023;8(23):e172192.
transmission and motor performance with LRRK2
overexpression in mice is eliminated by familial Parkinson’s doi: 10.1172/jci.insight.172192
disease mutation G2019S. J Neurosci. 2010;30(5):1788-1797. 25. Zhang Q, Liu M, Xu Y, et al. Tilorone mitigates the
propagation of α-synucleinopathy in a midbrain-like
doi: 10.1523/JNEUROSCI.5604-09.2010
organoid model. J Transl Med. 2024;22(1):816.
15. Cebrian C, Loike JD, Sulzer D. Neuroinflammation in
Parkinson’s disease animal models: A cell stress response doi: 10.1186/s12967-024-05551-7
or a step in neurodegeneration? Curr Top Behav Neurosci. 26. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2

Volume 1 Issue 2 (2025) 9 doi: 10.36922/OR025040006